These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38914626)

  • 1. Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytial virus subtypes A and B.
    Holmdahl I; Bents SJ; Baker RE; Casalegno JS; Trovão NS; Park SW; Metcalf JE; Viboud C; Grenfell B
    Sci Rep; 2024 Jun; 14(1):14527. PubMed ID: 38914626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and viral loads of respiratory syncytial virus in hospitalized children prior to and during COVID-19 pandemic in Hangzhou, China.
    Chen Y; Zhao X; Ye C; Zhou J; Wang J; Ye X
    J Med Virol; 2024 Aug; 96(8):e29855. PubMed ID: 39119991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data.
    Ravkin HD; Yom-Tov E; Nesher L
    J Med Internet Res; 2022 Dec; 24(12):e42781. PubMed ID: 36476385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory Syncytial Virus Outbreaks Are Predicted after the COVID-19 Pandemic in Tokyo, Japan.
    Madaniyazi L; Seposo X; Ng CFS; Tobias A; Toizumi M; Moriuchi H; Yoshida LM; Hashizume M
    Jpn J Infect Dis; 2022 Mar; 75(2):209-211. PubMed ID: 34470964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-Depth Analysis of the Re-Emergence of Respiratory Syncytial Virus at a Tertiary Care Hospital in Germany in the Summer of 2021 after the Alleviation of Non-Pharmaceutical Interventions Due to the SARS-CoV-2 Pandemic.
    Hönemann M; Thiem S; Bergs S; Berthold T; Propach C; Siekmeyer M; Frille A; Wallborn T; Maier M; Pietsch C
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole genome molecular analysis of respiratory syncytial virus pre and during the COVID-19 pandemic in Free State province, South Africa.
    Sondlane H; Ogunbayo A; Donato C; Mogotsi M; Esona M; Hallbauer U; Bester P; Goedhals D; Nyaga M
    Virus Res; 2024 Sep; 347():199421. PubMed ID: 38942296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis.
    Leija-Martínez JJ; Esparza-Miranda LA; Rivera-Alfaro G; Noyola DE
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence analysis of respiratory syncytial virus cases reveals a novel subgroup -B strain circulating in north-central Italy after pandemic restrictions.
    Pierangeli A; Midulla F; Piralla A; Ferrari G; Nenna R; Pitrolo AMG; Licari A; Marseglia GL; Abruzzese D; Pellegrinelli L; Galli C; Binda S; Cereda D; Fracella M; Oliveto G; Campagna R; Petrarca L; Pariani E; Antonelli G; Baldanti F
    J Clin Virol; 2024 Aug; 173():105681. PubMed ID: 38733664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children.
    Lu Y; Chen Q; Ren S; Zhang Y; Yi L; Qian C; Shen J; Liu X; Jiang M; Wang B; Song J; Shao X; Zhang T; Tian J; Zhao G
    Influenza Other Respir Viruses; 2024 Apr; 18(4):e13291. PubMed ID: 38653953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 Pandemic Restrictions on Respiratory Virus Patterns: Insights from RSV Surveillance in Gwangju, South Korea.
    Cho SJ; Kim SH; Mun J; Yun JE; Park S; Park J; Lee YU; Park JS; Yun H; Lee CM; Kim JP; Seo JM
    Viruses; 2024 May; 16(6):. PubMed ID: 38932143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa.
    Bents SJ; Viboud C; Grenfell BT; Hogan AB; Tempia S; von Gottberg A; Moyes J; Walaza S; Hansen C; Cohen C; Baker RE
    Influenza Other Respir Viruses; 2023 Dec; 17(12):e13229. PubMed ID: 38090227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China.
    Jiang ML; Xu YP; Wu H; Zhu RN; Sun Y; Chen DM; Wang F; Zhou YT; Guo Q; Wu A; Qian Y; Zhou HY; Zhao LQ
    J Med Virol; 2023 Jan; 95(1):e28411. PubMed ID: 36524893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RSV through the COVID-19 pandemic: Burden, shifting epidemiology, and implications for the future.
    Stein RT; Zar HJ
    Pediatr Pulmonol; 2023 Jun; 58(6):1631-1639. PubMed ID: 36811330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19.
    Rice E; Oakes DB; Holland C; Moore HC; Blyth CC
    Curr Opin Infect Dis; 2023 Dec; 36(6):522-528. PubMed ID: 37830952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological characteristics of respiratory viruses in hospitalized children during the COVID-19 pandemic in southwestern China.
    Zhu L; Luo T; Yuan Y; Yang S; Niu C; Gong T; Wang X; Xie X; Luo J; Liu E; Fu Z; Tian D
    Front Cell Infect Microbiol; 2023; 13():1142199. PubMed ID: 37153160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the impact of non-pharmaceutical interventions on RSV transmission in a single-centre observational study.
    Betts TA; Darby AE; Hussain F; Edwards M
    BMJ Paediatr Open; 2024 Jun; 8(1):. PubMed ID: 38897622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus incidence and typing in the last six seasons in the north of Spain (Asturias). Genetic characterization during the SARS-CoV-2 pandemic.
    Rojo-Alba S; Martínez ZP; González-Alba JM; Boga JA; Varela CO; Álvarez MAA; Fonseca CP; Clemente MMG; Rodriguez JG; García EG; Pérez MR; García SM; Álvarez-Argüelles ME
    J Med Virol; 2024 Mar; 96(3):e29499. PubMed ID: 38469919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of public health measures during the SARS-CoV-2 pandemic on the winter respiratory syncytial virus epidemic: An interrupted time series analysis.
    Reyes Domínguez AI; Pavlovic Nesic S; Urquía Martí L; Pérez González MDC; Reyes Suárez D; García-Muñoz Rodrigo F
    Paediatr Perinat Epidemiol; 2022 May; 36(3):329-336. PubMed ID: 34981845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global patterns of rebound to normal RSV dynamics following COVID-19 suppression.
    Thindwa D; Li K; Cooper-Wootton D; Zheng Z; Pitzer VE; Weinberger DM
    BMC Infect Dis; 2024 Jun; 24(1):635. PubMed ID: 38918718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures.
    Billard MN; van de Ven PM; Baraldi B; Kragten-Tabatabaie L; Bont LJ; Wildenbeest JG
    Influenza Other Respir Viruses; 2022 Sep; 16(5):926-936. PubMed ID: 35733362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.